0 01/09/2023 31/08/2024 2024-08-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2023-09-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 09787157 2023-09-01 2024-08-31 09787157 2024-08-31 09787157 2023-08-31 09787157 2022-09-01 2023-08-31 09787157 2023-08-31 09787157 2022-08-31 09787157 bus:RegisteredOffice 2023-09-01 2024-08-31 09787157 bus:Director1 2023-09-01 2024-08-31 09787157 bus:Director2 2023-09-01 2024-08-31 09787157 bus:Director3 2023-09-01 2024-08-31 09787157 core:WithinOneYear 2024-08-31 09787157 core:WithinOneYear 2023-08-31 09787157 bus:Micro-entities 2023-09-01 2024-08-31 09787157 bus:AuditExempt-NoAccountantsReport 2023-09-01 2024-08-31 09787157 bus:SmallCompaniesRegimeForAccounts 2023-09-01 2024-08-31 09787157 bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 09787157 bus:FullAccounts 2023-09-01 2024-08-31
Company registration number: 09787157
Metapharma Ltd
Unaudited filleted financial statements
31 August 2024
Metapharma Ltd
Contents
Directors and other information
Statement of financial position
Metapharma Ltd
Directors and other information

| Directors | Amit Seda
|  | Deepak Seda
|  | Sandeep Singh
| Company number | 09787157
| Registered office | 94 Great South West Road
|  | Hounslow
|  | TW4 7NF

Metapharma Ltd
Statement of financial position
31 August 2024

|  |  | 2024 |  | 2023 |  |
|  |  | £ |  | £ |  |
Current assets |  |  | 4,000 |  | 4,000 |  |
Creditors: amounts falling due within one year |  |  | ( 6,137) |  | ( 5,580) |  |
|  |  | _______ |  | _______ |  |
Net current liabilities |  |  | ( 2,137) |  | ( 1,580) |  |
|  |  | _______ |  | _______ |  |
Total assets less current liabilities |  |  | ( 2,137) |  | ( 1,580) |  |
|  |  | _______ |  | _______ |  |
Net liabilities |  |  | ( 2,137) |  | ( 1,580) |  |
|  |  | _______ |  | _______ |  |
Capital and reserves |  |  | ( 2,137) |  | ( 1,580) |  |
|  |  | _______ |  | _______ |  |

Metapharma Ltd
Year ended 31 August 2024
For the year ending 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 26 May 2025 , and are signed on behalf of the board by:
Amit Seda
Director
Company registration number: 09787157
The company is a private company limited by shares, registered in England.